Detalhe da pesquisa
1.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870594
2.
Central Diabetes Insipidus in a Patient With Lymphoma: A Case Report.
Cureus
; 15(7): e41500, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551214
3.
Autophagy and cellular senescence in classical Hodgkin lymphoma.
Pathol Res Pract
; 236: 153964, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700577
4.
Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.
In Vivo
; 36(3): 1302-1315, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35478115
5.
Expression, prognostic significance and mutational analysis of protein tyrosine phosphatase SHP-1 in chronic myeloid leukemia.
Leuk Lymphoma
; 57(5): 1182-8, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26373709
6.
Rare variants in the spectrum of human herpesvirus 8/Epstein-Barr virus-copositive lymphoproliferations.
Hum Pathol
; 46(10): 1566-71, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26299509
7.
Revisiting bleomycin from pathophysiology to safe clinical use.
Crit Rev Oncol Hematol
; 87(1): 90-100, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23312772